Securities Class Action

No Litigation found for Apimeds Pharmaceuticals US, Inc.

Material Events

Critical Governance & Disclosure

15

Board, Voting & Shareholder Rights

23

Capital Structure & Financial Risk

4

Disclosure & Communications

23

SEC Filings

8-K

Current report

2026-11-20

View 8-K Current report on SEC.gov
DEF 14A

Other definitive proxy statements

2026-11-18

View DEF 14A Other definitive proxy statements on SEC.gov
Form 3

Initial statement of beneficial ownership of securities

2026-11-05

View Form 3 Initial statement of beneficial ownership of securities on SEC.gov
Form 3

Initial statement of beneficial ownership of securities

2026-11-02

View Form 3 Initial statement of beneficial ownership of securities on SEC.gov
Form 3

Initial statement of beneficial ownership of securities

2026-11-02

View Form 3 Initial statement of beneficial ownership of securities on SEC.gov

Insider Transaction

No Insider Transactions found for Apimeds Pharmaceuticals US, Inc.